Generic Drug Labeling Rule = Product Liability Suits = Higher Prices, Study Says
This article was originally published in The Pink Sheet Daily
Executive Summary
GPhA-sponsored economic analysis of FDA’s proposed rule estimates it will increase consumer spending on generic drugs by $4 billion annually.